financetom
Business
financetom
/
Business
/
CareMax Shares Are Up By More Than 200%: What You Need To Know
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CareMax Shares Are Up By More Than 200%: What You Need To Know
Jul 22, 2024 12:55 PM

Shares of CareMax, Inc ( CMAX ). are trading significantly higher on Monday. Here’s what you need to know.

CareMax ( CMAX ) is experiencing a surge in trading volume, with session volume reaching 72.9 million shares, far exceeding its 100-day average volume of 328K shares.

How to Buy CareMax Shares?

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of CareMax, Inc ( CMAX ). , which is trading at $6.09 as of publishing time, $100 would buy you 16.42 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

CMAX Price Action: CareMax ( CMAX ) shares are up by 282.3% at $6.03 at the time of writing, according to Benzinga Pro.

See Also:

Coca-Cola Pops Bullish Ahead Of Q2 Earnings: Will The Fizz Last?

Image: Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Data-loss prevention company Cyberhaven hit by breach, statement says
Data-loss prevention company Cyberhaven hit by breach, statement says
Dec 27, 2024
Hackers compromised an employee of the data-protection company Cyberhaven and used the worker's access to potentially steal sensitive information from the firm's users, the company said in a statement distributed to customers and reviewed by Reuters.     The hackers pushed a compromised version of Cyberhaven's Chrome browser extension to the company's users early on Wednesday, the statement said. The company urged affected...
US FDA approves injectable form of Bristol Myers' Opdivo
US FDA approves injectable form of Bristol Myers' Opdivo
Dec 27, 2024
Dec 27 (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ( BMY ) blockbuster cancer drug, Opdivo. ...
UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny
UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny
Dec 27, 2024
11:29 AM EST, 12/27/2024 (MT Newswires) -- UnitedHealth Group ( UNH ) and Amedisys ( AMED ) agreed to extend the deadline of their proposed merger as the deal faces scrutiny from the US Department of Justice over competition concerns. UnitedHealth ( UNH ), through its Optum subsidiary, agreed in June 2023 to acquire home health and hospice services provider...
Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study
Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study
Dec 27, 2024
11:20 AM EST, 12/27/2024 (MT Newswires) -- Vaxart ( VXRT ) said an agreement with Advanced Technology International on a COVID-19 vaccine candidate study was amended with an increase of $4.6 million in the total estimated ceiling for funding to $460.7 million. The project agreement in June covered funding for a comparative study to evaluate the company's oral pill XBB...
Copyright 2023-2026 - www.financetom.com All Rights Reserved